Moreover, NAMS' discussions on funding such an expansive study remain internal, leaving uncertainties in its capital allocation.

Source: https://seekingalpha.com/article/4629790-newamsterdam-pharma-best-cardiovascular-biotech-in-2023?source=feed_all_articles

There are lots a woman can do to stave off these symptoms before, during and even after menopause, said NAMS medical director Dr. Stephanie Faubion, director of the Mayo Clinic Center for Women's Health in Rochester, Minn.

Source: https://www.gjsentinel.com/lifestyle/health_and_wellness/menopause-symptoms-can-arise-well-before-menopause-study/article_c646d708-af03-530f-b432-d6f1045b904f.html

We believe, if NAMS can further validate this theory with larger, placebo-controlled studies in the future, the Alzheimer's pipeline could emerge as a vital, yet currently underappreciated, component of the company's value proposition.

Source: https://seekingalpha.com/article/4638584-new-amsterdam-pharma-stock-pioneering-pulse-alzheimers-breakthroughs?source=feed_all_articles